Fusing the high target selectivity of monoclonal antibodies with potent small-molecule cytotoxic payloads is accelerating transformative growth across targeted cancer therapeutics. Detailed analysis within the Antibody Drug Conjugate Market report demonstrates how next-generation antibody-drug conjugates (ADCs) utilize optimized cleavable linkers and site-specific bioconjugation chemistry to...